Competition: An Antidote to the High Price of Prescription Drugs
- Topics:
- Healthcare Services,
- Pharmeceuticals
- Source:
- Project HOPE
FREE Registration is required
Overview: Patent protection and factors unique to prescription drugs weaken the forces keeping prices near costs for other products. A growing public consensus that affordable drugs should be available to all is likely to increase the upward pressure on prices. To restore competition to all parts of the pharmaceutical industry, this article proposes a new institute at the National Institutes of Health that would compete with the private sector for pharmaceutical intellectual property by establishing competition for research and development contracts open to public and private institutions; retain the resulting patents; and grant cost-free, nonexclusive licenses to all qualified producers.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 100KB | Date: Aug 2004 | Pages: 8
People who downloaded this item also downloaded
![]() |
Everything is Negotiable, and Everything is a Negotiation |
![]() |
Coaching Techniques for Dealing with Underperformers |
![]() |
Pick Up Your Underperformers |




